Hemogenyx Pharmaceuticals Share Discussion Threads

[apotheki] 14/2/2024 08:19

Taken from X formally known as Tw*tt*r reference valuation comparisons with peer group....

justamantrading
@justamantrading

Good time to revisit peer to peer review and valuations today. We are now finally clinical ladies and gents. The movement today is likely to be volatile but let funding be clarified and we should fly. I expect this to be a positive funding announcement personally. #HEMO

[apotheki] 14/2/2024 08:16

One of the things that I really like about Hemogenyx Pharmaceuticals is that it is clearly NOT going to be a one trick pony!

[premium beeks] 14/2/2024 08:15

Seems very good news again. All helps the story.

[gah123] 14/2/2024 08:14

Starting to take offa

[gah123] 14/2/2024 08:10

Looking good

[apotheki] 14/2/2024 08:10

Just another AI controlled bot aka TROLL

[ashleyjv] 14/2/2024 08:09

seems as if you have a doppelganger gah123 lol

[gah123] 14/2/2024 08:04

What a great RNS, back to 6p+

[apotheki] 14/2/2024 07:50

For the benefit of all new investors....

About Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals is a publicly traded company (LSE:HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.

The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

[apotheki] 14/2/2024 07:46

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "This major breakthrough in the method of delivery of our CBR demonstrates that it could potentially be used as an off-the-shelf prevention and/or treatment for viral infections. Intranasal delivery of CBR would be both cost-efficient and easy to administer, making it ideal for the protection of both the civilian population and in biodefense."

[loglorry1] 14/2/2024 07:25

It does seem like HEMO have a potential cure for everything. Quite incredible for a one man band and his lawyer wife. I wonder if they'll do cold fusion also.

Funny how they get this out just as the price is slipping and they are desperate for cash and need to raise.

[luckyabbeygale] 14/2/2024 07:12

Wow what a great rns and this means we will bounce strongly today. As the target will be the 7p that was paid in auction last Friday. Not only waking up to this. I also see that my Fusion Antibodies has a huge raise at its bid price.

[ashleyjv] 14/2/2024 07:11

CBR Intranasal Delivery



Chimeric Bait Receptors for Combatting Airborne Viral Infections Can Be Delivered Intranasally





Hemogenyx Pharmaceuticals plc (LSE: HEMO), the clinical stage biopharmaceutical group, announces that it has demonstrated in vivo that its proprietary Chimeric Bait Receptor ("CBR") can be delivered intranasally in the form of messenger RNA ("mRNA") for the potential treatment of airborne viral infections.

CBR-based countermeasures against viral infections that are include a novel method of their delivery. To satisfy real-world requirements for the deployment of such countermeasures, they must be both easy to administer and have a long shelf life at ambient temperatures. CBR is a platform technology under development that aims to program the immune cells that are responsible for innate immunity (e.g., macrophages) to eliminate viruses and certain malignant cells.

Our team of scientists has demonstrated in vivo that mRNA encoding a CBR-based therapeutic can be mixed with a polymer and a solvent at room temperature to form polymer nanoparticles encapsulating mRNA. Such nanoparticles can be used to deliver CBR-coding mRNA into the upper respiratory tract ("URT") and lungs of small animals. Once administered, nanoparticles were shown to successfully deliver mRNA into the immune cells of the URT and lungs. The immune cells in turn begin making CBR molecules within hours post-application, potentially becoming active "defenders" against airborne infections.

As previously reported, the Company has been able to dramatically accelerate its research and development efforts by using Artificial Intelligence ("AI") and in-house synthesis of mRNA. AI tools allow the Company's scientists to triage variants of CBR constructs efficiently to select those with the greatest likelihood of success, while in-house mRNA synthesis facilitates the rapid building of CBR constructs.

Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals, commented: "This major breakthrough in the method of delivery of our CBR demonstrates that it could potentially be used as an off-the-shelf prevention and/or treatment for viral infections. Intranasal delivery of CBR would be both cost-efficient and easy to administer, making it ideal for the protection of both the civilian population and in biodefense."

[gahi23] 14/2/2024 06:28

Overpriced by 2p !

[gahi23] 14/2/2024 06:28

Because it is a turkey hahahahaha

[gahi23] 14/2/2024 06:25

Mugs been sold a puppy here hahahaha

[gahi23] 14/2/2024 06:25

Below a penny is fair value for this lemon ! Further to fall yet ahhahahahahahaCant stop laughing ! Let that sink in !

[luckyabbeygale] 13/2/2024 16:35

Well it nearly sent me to the porpers yard when HEMO and QBT both dropped at the same time. My margin was just over 150 percent. I had to close Jubilie Platinum just incase the margin limit is 150 percent. I know on IG Index the margin limit is 50 percent. I do not know what it is on Spread X.

At the end of the day I got back everything thanks to QBT going back up.

[apotheki] 13/2/2024 16:15

Noted your earlier post luckyabbeygate reference your various purchases via CFDs so good luck with it!

[apotheki] 13/2/2024 16:10

Despite having just had FDA approval last Friday the shares have now more than halved in value from an intra day high of 6.30p last Friday to circa 3p today so I took full advantage down at these low levels where I consider the shares to not only be really undervalued but also very over sold!

[premium beeks] 13/2/2024 16:09

I doubt a promoter on here would make a dent in the price, up or down.

[albert35911] 13/2/2024 15:52

He couldn’t pump up a ballon.